Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGames Workshop Regulatory News (GAW)

Share Price Information for Games Workshop (GAW)

Share Price is delayed by 15 minutes
Get Live Data
18,980.00    -120.00 (-0.63%)
Bid:
18,980.00
Ask:
19,010.00
Spread: 30.00 (0.158%)
Market Cap: £6.27b
GAW Live PriceLast checked at - London Stock Exchange

Intraday Games Workshop Share Chart

Director Declaration

22 Nov 2021 07:00

RNS Number : 0459T
Games Workshop Group PLC
22 November 2021
 

22 November 2021

Games Workshop Group PLC

("Games Workshop" or the "Company")

Disclosure of New Directorship

 

Games Workshop announces that Kate Marsh, an independent non-executive director of the Company, has become an independent non-executive director of Devolver Digital Inc. as listed on the Alternative Investment Market of the London Stock Exchange.

For further information please contact:

Ross Matthews

Group Company Secretary

investorrelations@gwplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNBBBBTMTTTTTB
Date   Source Headline
8th Jun 20187:00 amRNSTrading Statement
1st Jun 201810:39 amRNSTotal Voting Rights
4th May 20187:00 amRNSTrading Statement
16th Apr 201811:55 amRNSHolding(s) in Company
27th Mar 20189:23 amRNSDirector/PDMR Shareholding
1st Mar 20187:00 amRNSBlock listing Interim Review
1st Mar 20187:00 amRNSTotal Voting Rights
8th Feb 20183:47 pmRNSDirector/PDMR Shareholding
5th Feb 201812:01 pmRNSTrading update and dividend
1st Feb 20187:00 amRNSTotal Voting Rights
29th Jan 201811:36 amRNSDirector/PDMR Shareholding
25th Jan 201811:06 amRNSDisclosure of new directorship
22nd Jan 20189:13 amRNSDirector/PDMR Shareholding
9th Jan 20187:00 amRNSHalf-year Report
2nd Jan 20187:00 amRNSTotal Voting Rights
13th Dec 201712:02 pmRNSDividend Declaration
8th Dec 20174:12 pmRNSHolding(s) in Company
1st Dec 20177:00 amRNSTrading Statement
1st Dec 20177:00 amRNSTotal Voting Rights
2nd Nov 20173:55 pmRNSDirector/PDMR Shareholding
30th Oct 20174:32 pmRNSDirector/PDMR Shareholding
19th Oct 20177:00 amRNSTrading Statement
28th Sep 20171:36 pmRNSDirector/PDMR Shareholding
18th Sep 201710:21 amRNSBlock listing application
13th Sep 20171:00 pmRNSAGM Statement
5th Sep 20177:00 amRNSDividend and Trading Statement
1st Sep 201711:25 amRNSBlock listing Interim Review
1st Sep 201710:46 amRNSHolding(s) in Company
1st Sep 20177:00 amRNSTotal Voting Rights
9th Aug 201711:29 amRNSHolding(s) in Company
7th Aug 201711:30 amRNSHolding(s) in Company
3rd Aug 20174:52 pmRNSAnnual Financial Report
25th Jul 20177:00 amRNSDirectorate Change
25th Jul 20177:00 amRNSAnnual Financial Report
25th Jul 20177:00 amRNSTrading Statement
21st Jul 20171:10 pmRNSDirector/PDMR Shareholding
21st Jul 201712:06 pmRNSHolding(s) in Company
3rd Jul 20177:00 amRNSTotal Voting Rights
19th Jun 20174:05 pmRNSHolding(s) in Company
14th Jun 20177:00 amRNSDividend Declaration
2nd Jun 20172:17 pmRNSDirector/PDMR Shareholding
2nd Jun 201712:37 pmRNSTrading Statement
1st Jun 20177:00 amRNSTotal Voting Rights
2nd May 201711:32 amRNSTotal Voting Rights
3rd Apr 20177:00 amRNSTotal Voting Rights
22nd Mar 20171:23 pmRNSDividend Declaration
6th Mar 20171:36 pmRNSDirector/PDMR Shareholding
6th Mar 201711:51 amRNSTrading Statement
2nd Mar 201710:57 amRNSHolding(s) in Company
1st Mar 20177:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.